FIELD: medicine, gastroenterology. SUBSTANCE: invention relates to methods used for decrease of gastroenteric tract motor system activity or delay of stomach emptying. Invention proposes to use amyline or amyline agonist. Method provides the effective treatment of patients with diseases and states where is necessarily to suppress motor system activity of stomach and other regions of gastroenteric tract. EFFECT: enhanced effectiveness of method. 16 cl, 2 tbl, 17 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING DIABETES TYPE II WITH AMYLENE ANTAGONISTS | 1996 |
|
RU2166958C2 |
| METHODS OF OBESITY TREATMENT | 1998 |
|
RU2207871C2 |
| METHOD FOR TREATMENT OR PROPHYLAXIS OF OBESITY | 2002 |
|
RU2314121C9 |
| METHOD FOR DECREASING OF NUTRIENT AVAILABILITY AND METHOD FOR APPETITE SUPPRESSION | 2001 |
|
RU2275207C2 |
| NEW COMPOSITIONS OF EXENDINE AGONISTS AND METHODS OF THEIR ADMINISTRATION | 2000 |
|
RU2242244C2 |
| METHOD FOR INHIBITING GLUCAGON | 2000 |
|
RU2247575C9 |
| ANALOG-AGONIST OF AMYLINE, ITS PHARMACEUTICALLY ACCEPTABLE SALTS, COMPOSITION EXHIBITING PROPERTIES OF AMYLINE AGONIST | 1992 |
|
RU2130463C1 |
| PEPTIDE HAVING AMYLIN PROPERTIES (VERSIONS) AND USE THEREOF (VERSIONS) | 2005 |
|
RU2385878C2 |
| METHODS OF DIABETES TREATMENT AND BODY WEIGHT REDUCTION | 2006 |
|
RU2421237C2 |
| TREATING DIABETES AND METABOLIC SYNDROME | 2010 |
|
RU2537181C2 |
